<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Loll B</dc:creator>
  <dc:creator>Fabian H</dc:creator>
  <dc:creator>Huser H</dc:creator>
  <dc:creator>Hee CS</dc:creator>
  <dc:creator>Ziegler A</dc:creator>
  <dc:creator>Uchanska-Ziegler B</dc:creator>
  <dc:creator>Ziegler A</dc:creator>
  <dc:date>2016</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">OBJECTIVE
Dissimilarities in antigen processing and presentation are known to contribute to the differential association of HLA-B*27 subtypes with the inflammatory rheumatic disease ankylosing spondylitis (AS). In support of this notion, previous x-ray crystallographic data showed that peptides can be displayed by almost identical HLA-B*27 molecules in a subtype-dependent manner, allowing cytotoxic T lymphocytes to distinguish between these subtypes. For example, a human self-peptide derived from vasoactive intestinal peptide receptor type 1 (pVIPR; sequence RRKWRRWHL) is displayed in a single conformation by B*27:09 (which is not associated with AS), while B*27:05 (which is associated with AS) presents the peptide in a dual binding mode. In addition, differences in conformational flexibility between these subtypes might affect their stability or antigen presentation capability. This study was undertaken to investigate B*27:04 and B*27:06, another pair of minimally distinct HLA-B*27 subtypes, to assess whether dual peptide conformations or structural dynamics play a role in the initiation of AS.


METHODS
Using x-ray crystallography, we determined the structures of the pVIPR-B*27:04 and pVIPR-B*27:06 complexes and used isotope-edited infrared (IR) spectroscopy to probe the dynamics of these HLA-B*27 subtypes.


RESULTS
As opposed to B*27:05 and B*27:09, B*27:04 (which is associated with AS) displays pVIPR conventionally and B*27:06 (which is not associated with AS) presents the peptide in a dual conformation. Comparison of the 4 HLA-B*27 subtypes using IR spectroscopy revealed that B*27:04 and B*27:05 possess elevated molecular dynamics compared to the nonassociated subtypes B*27:06 and B*27:09.


CONCLUSION
Our results demonstrate that an increase in conformational flexibility characterizes the disease-associated subtypes B*27:04 and B*27:05.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/174094</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1002/art.39567</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/26748477</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Arthritis &amp; rheumatology (Hoboken, N.J.). - 2016</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Crystallography, X-Ray</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">HLA-B27 Antigen</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Molecular Conformation</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Molecular Docking Simulation</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Protein Binding</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Protein Conformation</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Receptors, Vasoactive Intestinal Polypeptide, Type I</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Spectroscopy, Fourier Transform Infrared</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Spondylitis, Ankylosing</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">T-Lymphocytes, Cytotoxic</dc:subject>
  <dc:title xmlns:ns12="xml" ns12:lang="en">Increased Conformational Flexibility of HLA-B*27 Subtypes Associated With Ankylosing Spondylitis.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
